Quick Takeaways
- Philippe Amouyal has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,722,321.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Philippe Amouyal
- Location
- Washington, DC
- Summary
- The estimated net worth of Philippe Amouyal is at least $1,722,321 dollars as of 24 Jun 2025. Philippe Amouyal is the Director of CAVA GROUP, INC. and owns shares of CAVA GROUP, INC. (CAVA) stock worth about $1.48M. Philippe Amouyal is the Director of LEXICON PHARMACEUTICALS, INC. and owns shares of LEXICON PHARMACEUTICALS, INC. (LXRX) stock worth about $241.9K.
- Signature
- /s/ Kenneth Robert Bertram, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Philippe Amouyal and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: CAVA GROUP, INC. ($1,480,441).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Philippe Amouyal
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CAVA | CAVA GROUP, INC. | Director | $1,480,441 | 20 Jun 2025 | ||
| LXRX | LEXICON PHARMACEUTICALS, INC. | Director | $241,880 | 03 Jun 2025 |
Insider Transactions Reported by Philippe Amouyal:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.